Lakatos, Eszter https://orcid.org/0000-0002-7221-6850
Gunasri, Vinaya
Zapata, Luis
Househam, Jacob https://orcid.org/0000-0003-3199-336X
Heide, Timon https://orcid.org/0000-0002-1386-7469
Trahearn, Nicholas https://orcid.org/0000-0002-8596-0996
Swinyard, Ottilie
Cisneros, Luis https://orcid.org/0000-0002-7890-1269
Lynn, Claire
Mossner, Maximilian
Kimberley, Chris
Spiteri, Inmaculada https://orcid.org/0000-0002-1097-8972
Cresswell, George D. https://orcid.org/0000-0003-3303-068X
Llibre-Palomar, Gerard https://orcid.org/0000-0002-4741-3473
Mitchison, Miriam
Maley, Carlo C. https://orcid.org/0000-0002-0745-7076
Jansen, Marnix https://orcid.org/0000-0003-0645-564X
Rodriguez-Justo, Manuel https://orcid.org/0000-0001-5007-1761
Bridgewater, John
Baker, Ann-Marie https://orcid.org/0000-0001-8905-9137
Sottoriva, Andrea https://orcid.org/0000-0001-6709-9533
Graham, Trevor A. https://orcid.org/0000-0001-9582-1597
Funding for this research was provided by:
Wellcome Trust (202778/Z/16/Z)
Wellcome Trust (202778/B/16/Z)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA217376)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA217376)
Vetenskapsrådet (VR2024-04145)
Chalmers Area of Advance Health Engineering, Gender Initiative for Excellence
Pathological Society of Great Britain and Ireland (JSPS/CLG/1022/01)
Article History
Received: 12 February 2024
Accepted: 28 August 2025
First Online: 5 November 2025
Competing interests
: T.A.G. and A.-M.B. are listed as coinventors on patent application GB2305655.9 that concerns T cell receptor sequencing of cancers, and T.A.G. is a coinventor on patent application GB2317139.0 that concerns measurement of cancer evolutionary dynamics and GB2501439.0 that concerns evolutionary dynamics of cell lines under treatment. T.A.G. has received an honorarium from Genentech Inc. and provides consultancy for DAiNA therapeutics. The other authors declare no competing interests.